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Abstract
The innate immune response provides a first line of defense against pathogens by targeting generic differential features
that are present in foreign organisms but not in the host. These innate responses generate selection forces acting both in
pathogens and hosts that further determine their co-evolution. Here we analyze the nucleic acid sequence fingerprints of
these selection forces acting in parallel on both host innate immune genes and ssRNA viral genomes. We do this by
identifying dinucleotide biases in the coding regions of innate immune response genes in plasmacytoid dendritic cells, and
then use this signal to identify other significant host innate immune genes. The persistence of these biases in the
orthologous groups of genes in humans and chickens is also examined. We then compare the significant motifs in highly
expressed genes of the innate immune system to those in ssRNA viruses and study the evolution of these motifs in the
H1N1 influenza genome. We argue that the significant under-represented motif pattern of CpG in an AU context - which is
found in both the ssRNA viruses and innate genes, and has decreased throughout the history of H1N1 influenza replication
in humans - is immunostimulatory and has been selected against during the co-evolution of viruses and host innate
immune genes. This shows how differences in host immune biology can drive the evolution of viruses that jump into
species with different immune priorities than the original host.
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Introduction
The innate immune system encompasses the non-specific
response of an organism to broad classes of foreign pathogens
[1]. At the cellular level, this process depends upon a cell’s ability
to recognize pathogenic material as ‘‘non-self’’ and react with an
appropriate defense. In the past several years, a great deal of
progress has been made in enumerating the different pattern
recognition receptors (PRRs) that recognize sets of pathogen-
associated molecular patterns (PAMPs) [2,3]. Examples include
the Toll-like receptors (TLRs), retinoic acid-inducible gene-I
(RIG-I) like receptors, and Nod-like receptors (NLRs). The list
may grow as experiments continue probing pattern receptor
ligands both within and across species.
The ability of a pathogen to avoid or trigger recognition by the
innate immune system will likely affect its survival. Therefore,
advances in understanding immunostimulatory patterns cannot be
separated from our understanding of pathogen evolution. In the
evolution of RNA viruses, for instance, where the genetic mutation
rate is orders of magnitude higher than in the host’s genome, one
would expect that a virus’s evolutionary history strongly reflects its
exposure to host recognition receptors. One should therefore be
able to use an RNA virus replication time series to identify possible
triggers of non-self material. If many different RNA viruses co-
infecting the same host species have avoided certain sequence
motifs for reasons that are not functional or structural, one may
hypothesize that these patterns are PAMPs that the virus has
evolved to avoid.
In parallel, the cells that are involved in the immune response
might also avoid expressing genes that contain immunostimulatory
motifs that can trigger cytokines toxic to the host as well as to the
virus. The expression of immunostimulatory motifs in this situation
could produce a confounding signal that can instigate an
autoimmune reaction of potentially catastrophic consequences
for the host, such as a cytokine storm. Hence, genes expressed in
immune cells would avoid expressing these motifs and, conse-
quently, one could potentially identify genes expressed by immune
cells by analyzing the under-representation of these motifs.
Therefore, the parallel search for similar under-represented motifs
in viruses and their hosts can provide a method for identifying
immunostimulatory motifs and the genes that encode them in silico.
Finally, one can use the rapid time scale of viral evolution to
search for empirical evidence of selection against these patterns as
verification that they are in fact being avoided.
In this work we simultaneously analyze ssRNA virus evolution
and the host innate immune response for evidence of biases that
indicate parallel avoidance of nucleotide motifs that trigger an
innate immune response. This study was inspired by our previous
work, in which we noted that under-represented dinucleotide
patterns in ssRNA viruses are often host specific and, moreover,
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dating back to the pandemic 1918 H1N1 virus [4]. It is clear from
that analysis that human influenza has been evolving in a manner
that lowers CpG content in a way that lacks a straightforward
explanation. In that paper we hypothesized that this change
decreases recognition of the virus as non-self, even though there is
no known innate immune receptor or other mechanism for
recognizing CpG in ssRNA. There is known recognition of CpG
in DNA (bound to by TLR9 [5]) and ssRNA (bound to by TLR 7
and 8 with possible context specificity [6–8]), along with
experiments indicating that CpG in ssRNA may be immunosti-
mulatory [9]. We believe this hypothesis, in part, due to
observations in Ref. [4] comparing the dinucleotide distribution
of coding sequence (CDS) regions in human and chicken mRNA.
The human CDS regions have a lower CpG content than
chickens, and we noted that some of the human genes with the
lowest CpG content, such as type I interferons, are involved in
innate immunity. We speculated in that work that the higher CpG
signal in the 1918 virus could have contributed to its increased
lethality via a high cytokine response and that a set of highly
expressed innate immune genes may also avoid a CpG signal so as
to avoid a deleterious positive feedback loop.
As expression is cell and tissue specific, the immune selection
forces that act on RNAs in cells will be determined by the
repertoire and quantity of innate immune recognition mecha-
nisms that a cell type expresses. In this work we focus on RNA
expression in plasmacytoid dendritic cells (pDCs). Discovered by
O’Doherty, et al., in 1994, pDCs are known to be the most
efficient interferon producing cells [10,11]. Despite comprising
about 1% of peripheral blood mononuclear cells, pDCs are often
the dominant producers of type I interferon in an antiviral
response [12–14]. Therefore, if the innate immune response to
viruses were to trigger harmful positive feedback via the
production of cytokines, pDCs would be likely to highly express
RNA involved in mediating this effect. These cells have already
been implicated in autoimmune diseases such as systematic lupus
erythematosus (SLE) and arthritis [15–17]. For instance,
researchers have attempted to link SLE to sex-linked over-
expression of TLR7, and, accordingly, to the over-sensitivity of
the immune response to stimulatory ssRNA when pDCs engulf
extra-cellular debris, such as may be generated following virus
induced cell death [18]. The level of PRR expression could also
change within immune cells during the anti-viral response,
creating heightened sensitivity to an associated signal. While it is
not clear that pDCs are the cell type involved in the recognition
we are proposing, they are chosen here due to their favorable
expression profile.
Clearly, there are many plausible scenarios where innate
immune gene mRNA and ssRNA viruses may experience a
common pressure to avoid triggering immunostimulatory signals
as much as is possible throughout their evolutionary history. This
pressure would become apparent at different time scales, given the
comparatively rapid pace of viral evolution. For instance, if a DNA
virus jumps from a species lacking TLR9 CpG sensitivity to a
species expressing this receptor, then one would expect a change in
CpG content as the virus evolves in its new host, possibly at a rapid
rate if the initial virus had a very high CpG content. Likewise,
innate immune genes, which are often expressed in large quantities
only during an infection would avoid immunostimulatory signals
so as to not create a positive feedback loop of cytokine
autoimmune response when they are taken in by pDCs or other
PRR expressing cells. Since this non-self signal is already low in
the host and the rate of host genetic evolution is typically slower
than in a virus, this will occur at a different rate.
Here we use public gene expression data generated by
Iparraguirre, et al., in mice [19] to identify significant nucleotide
biases in highly expressed genes during an innate response. In
these experiments, pDCs were stimulated with known influenza
and CpG DNA agonists in order to trigger an innate immune
response. Because this experiment examined pDC gene expression
against the background of the whole mouse genome, one can
measure how patterns in the expression data compare to those
observed in the mouse genome as a whole, and better understand
whether or not these patterns express a nucleic acid sequence
signal that can be contrasted with the overall mouse CDS profile.
Furthermore, we compare the under-represented motifs in innate
immune expressed genes to those in primate ssRNA viruses.
In this work we examine the nucleotide signals of both innate
immune genes CDS regions and ssRNA viruses to attempt to
answer two questions. The first is whether innate immune genes
contain a significant dinucleotide bias, such as that observed
previously in ssRNA viruses. We test this by determining whether
significant genes in mouse pDCs responding to influenza infection
and CpG DNA have sequence biases. We then compare these
biases across the genomes of humans and chickens since these
species are more commonly associated with influenza. The second
question, once this pattern is established, is whether or not the
CDS regions of ssRNA viruses and the expressed innate immune
genes share a similar pattern of over- and under-representation of
nucleotide motifs, and thus, whether or not innate immune genes
may have evolved to evade the same PRRs as ssRNA viruses so as
to avoid a positive feedback loop. We verify this hypothesis over
the 90 year time series of H1N1 influenza genome evolution in
humans.
Methods
The data used for this analysis was gathered from the following
sources. The 47 primate viral genomes were taken from reference
sequences in the NCBI (National Center for Biotechnology
Information) Viral Genomes Resource (http://www.ncbi.nlm.
nih.gov/genomes/VIRUSES/10239.html). These genomes were
used for studies in which a single reference sequence represented
each virus strain once, to allow for comparisons of classes of
viruses. We use primate viruses, since we wish to filter out any
species-specific effects that may result from the mouse model used
for the gene expression data. For analysis of the evolution of
influenza, genomes were taken from the Influenza Virus Resource
at NCBI, (http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.
html). This resource allowed us to examine a time series of
multiple samples from several strains. We used 674 human H1N1,
24 human H2N2, 1499 human H3N2, 65 human H5N1, 170
influenza B, and 969 avian influenza nucleotide sequences from
this resource in our previous work, but only the H1N1 data are
directly employed here. The full lists of the ssRNA viral reference
sequences and H1N1 viruses used in this analysis are available as
Supplementary Tables S1 and S2.
For the expression profile of stimulated mouse (Mus musculus)
pDC cells, the GCRMA normalized intensity data from Ref. [19]
is used. However, the statistical analysis is performed separately in
this work, since the questions asked are different than in the
original experiment. The portion of that experiment used in this
work consists of expression data for purified mouse pDC cells.
These cells were stimulated with CpG DNA to trigger TLR9 and
influenza RNA, presumably triggering TLR7. A control set was
also prepared. The gene expression was studied by Iparraguirre, et
al., using mouse MOE430v2 Gene Chip Microarray (Affymatrix,
Santa Clara, CA, USA). This data is publicly available from the
Oligo- Mediators RNA Innate
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geo/) under the record number GSE7831. As in that work, we use
the expression data generated 4 hours after stimulation to analyze
the innate response. For subsequent analysis, the coding regions
for all mouse genes were needed. All of these regions were taken
from the NCBI Consensus CDS database (http://www.ncbi.nlm.
nih.gov/projects/CCDS/CcdsBrowse.cgi). To correlate this in-
formation with homologous genes in humans (Homo sapiens) and
chickens (Gallus gallus), the Human Genome Nomenclature
Committee (HGNC) database is used to gather orthology
predictions between mouse, human, and chicken [20]. We analyze
the same coding information for the chicken and human genomes
to see whether the patterns discovered persist in the orthologous
genes in these species. As with the mouse CDS regions, the human
CDS sequences are also taken from the NCBI Consensus CDS
database [21,22]. The chicken genome CDS regions are obtained
from the University of California at Santa Cruz Genome Browser
(http://genome.ucsc.edu/) [23–26].
We use several metrics to measure the significance of nucleic
acid patterns in host and viral genomes. For the public expression
data of pathogen stimulated mouse genes [19], we desire a single
large expression value for each gene to avoid entangled data. For
this value, we use the base 2 logarithm of the ratio of the mean
expression level of the stimulated genes four hours after
stimulation in each trial to the mean of the control set before
stimulation. Thus the expression values listed later in this paper
are base 2 logarithms of the average intensity in stimulated probes
associated with a gene to control probes intensities associated with
that same gene. As noted by Iparraguirre, et al., four hours was the
time at which most key antiviral cytokines were expressed. We
then examine the mono- and dinucleotide frequency profile within
the coding regions of most expressed genes compared to the CDS
profile for the overall mouse genome. In the original experimental
analysis of Ref. [19], 2-fold expression was used as the cutoff for
designating a gene as significantly up-regulated. Therefore, we
start with that level as a minimum cutoff for designating a gene as
expressed.
Since we wish to examine whether the mono- or dinucleotide
frequency is skewed in highly expressed genes, we vary the cutoff
upwards by powers of two, and look at the frequency bias at each
power of two until the number of genes is insignificantly small. To
assess whether there is a greater abundance of expressed genes
with low or high frequencies of mono- or dinucleotides compared
to the overall genome, we divide the CDS frequency distribution
of the overall genome for that mono- or dinucleotide into quartiles
and tenths. We then use binomial statistics to evaluate, for each
power of 2, the probability that the number of expressed genes
that come from the highest and lowest tenths and quartiles of the
overall genome frequency could have occurred randomly. In this
way, we measure if the expressed genes have a significantly high or
low abundance of a particular mono- or dinucleotide frequency
when compared with all CDS regions of the genome. Moreover,
for the case of dinucleotides, we also examine the significance of
the ratio of the frequency of a dinucleotide over its expected value
given nucleotide content, which we refer to as the g statistic, by the
same procedure. This statistic, first used in this context by Karlin,
et al., [27,28], was also used in our previous work [4]. It takes
account of whether or not the observed dinucleotide frequency is
merely due a particular nucleotide content, as could happen when
a gene is located by chance in a region of the genome rich in a
particular nucleotide, such as an isochore.
To look for over- or under-represented motifs across sets of
genomes, such as all ssRNA viruses or all genes above a certain
threshold expression level, we utilize the novel set of randomiza-
tion algorithms for CDS regions employed in our previous work.
This generates randomized data for each individual genome by
creating a set of randomized genomes with the same amino acid
composition, sequence, and codon distribution. However, for each
amino acid, a codon is taken at random according to the true
codon distribution of the real sequence. Nucleotide content will
also be approximately preserved as a consequence. For a
particular motif, one can count the number of times that motif
appears in the real data and compare it to the average number of
times it occurs in the randomized sequences to get a better sense of
the bare pressures acting in excess of clear constraints. This
average can be taken across an individual gene, across a whole
genome, or across a set of genomes. For instance, if we wanted to
find patterns that are over- or under-represented across all ssRNA
viruses, we would concatenate the coding regions of each virus
together and apply the randomization to each whole virus CDS
region individually. However, we would take the averages across
all of the viruses of interest and compare them to the total real
count amongst all of the viruses. If we wanted to restrict ourselves
to individual viruses, then we would take the average only for that
virus. This method can also be applied to classes of host CDS
regions, such as those that respond to an immune stimulus in a
gene expression experiment. We employ this here to avoid
concatenating small innate immune genes when exploring
pressures beyond the dinucleotide level.
Once the real and expected value for a motif is obtained, we
employ the following measure. If we let N denote the number of
actual occurrences of a motif of a given length in a nucleotide
sequence and m denote the mean number of times that motif
occurs in a randomized set of sequences, then the measure r is
defined as
r~N=m:
This measure is similar to the odds ratios used by Karlin, but it
takes into account the protein sequence and codon bias, in
addition to nucleotide content. In Ref. [4] we defined r only for
dinucleotides that occur at the consecutive third and first positions
across codons. The other positions of dinucleotides are generally
accounted for entirely by the constraints of the algorithm: amino
acid composition, nucleotide frequency, and codon bias. Hence,
the above definition is a generalization of our previous one,
applicable to longer oligomers. As the above is somewhat
analogous to an odds ratio, one can derive confidence intervals
by analyzing the motif distribution in the randomized sequences.
Therefore, we can use this measure across classes of viral or host
CDS regions to establish the significance of motifs. While we
employ the r measure in this study, one can also use the
comparison between real and expected values to construct exact p-
values, as in [4], or other statistical measures that compare real
and expected values, such as z-scores. All of these methods provide
similar results.
Results
As a first step we compare the CpG profiles from mouse and
human genes to determine if they are similar enough to warrant
the use of mouse pDC expression data as the basis of this study.
The CDS regions of the mouse genome follow a similar CpG
dinucleotide pattern as the one reported in our previous work for
human CDS regions. In Figure 1, we plot g as a function of GC
content for both mouse and human CDS regions. Both overlap
considerably and have almost identical median g values of
approximately 0.42. The locations of the interferon alpha genes
Oligo- Mediators RNA Innate
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observed in the previous paper, the mouse plot has many low CpG
immune genes. Based on the similarity of these two graphs, as well
as the extremely low CpG content of the interferon alpha genes,
we expect that a mouse model will be comparable to a human
model for determining if innate immune genes are avoiding CpG
dinucleotides. Additionally, the correlation coefficient for CpG
frequency between human and mouse CDS regions is 0.78. A
histogram is shown of differences between CpG content in human
and mouse genes, which are then standardized. The distribution is
narrow and there is a small skewness (0.68) towards human genes.
While most gene are not very different, some of the genes with the
greatest differences are associated with HLA regions. The general
trend suggests that a broad mammalian pattern may be operative
here, and, in fact, we observe similar patterns to those seen in these
graphs in all available genomes of the mammalian superorder
Euarchontoglires, which split off from other mammals some 100
million years ago [unpublished observation by authors]. There-
fore, the fact that we are using mouse expression data should not
significantly constrain or bias this study.
We next analyze the gene expression profile of stimulated
mouse pDCs to look for dinucleotide biases in the most expressed
genes. A visual examination of expression level versus CDS
dinucleotide frequency gives a strong indication of low CpG bias
in the most expressed genes. We show two plots in Figure 2. The
first is the influenza stimulated expression level of mouse innate
genes versus CpG frequency in CDS regions of those genes at the
4 hour mark. The most expressed genes are clearly shifted toward
low frequency values. As a visual comparison, the second plot
shows expression versus ApT dinucleotide frequency, which shows
no apparant bias for influenza. Here it is visually clear that the
genes come randomly from the distribution. Analogous plots of
expression level versus g look simlar to those shown here.
These observations are statistically verified to insure that
observed low CpG bias is not a result of the low CpG frequency
of the genome in general. This step is performed for all
dinucleotides, so that any biases are noted. We start by examining
genes at the 2-fold expression level, following the original
reference, as our initial cutoff for increased levels of regulation
after exposure to influenza or CpG DNA [19]. For each
dinucleotide, we calculate the probability that the amount of
expressed genes whose dinucleotide frequencies are from the
highest and lowest tenths and quartiles of all genes could have
arisen randomly from the overall genome distribution for that
dinucleotide frequency. We check this further at each additional
two-fold expression level, as described in the methods. For clarity
of presentation, Table 1 and 2 only show dinucleotide bias in the
intersecting set of both CpG and influenza stimulated genes at the
Figure 1. Comparison of CpG Content for human and mouse CDS regions. A) CpG odds ratio (g) versus C+G content for CDS regions of all
human genes. The genes for Type I interferons are highlighted in red. B) CpG odds ratio (g) versus C+G content for CDS regions of all mouse genes.
The genes for Type I interferons are highlighted in red. C) Standardized histogram of differences between CpG frequency for CDS regions in human
versus mouse genes.
doi:10.1371/journal.pone.0005969.g001
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there are several genes whose frequency distribution appears
skewed at the quartile level when compared to the whole genome
distribution. For instance, CpG, GpC, and GG have far more
expressed genes in the lowest quartile, while GA has more in the
highest quartile. However, when one looks at the lowest and
highest tenths, only CpG is highly significant, with a p-value of less
than 10
25, indicating a strong pressure for the expressed genes to
have a low CpG frequency, even compared to the already low
CpG content of the entire genome.
The second set of columns in these tables show dinucleotiode
biases for the g statistic, rather than the CpG frequency, at each
level of expression. As a reminder, this statistic takes nucleotide
bias into account when determining dinucleotide representation.
Here a more refined story emerges. Only CpG is skewed lower
than in the general distribution. GA is skewed higher, though the
Figure 2. CpG bias in pDC expression vs CDS region CpG Content. A) log2 of the ratio of CpG stimulated pDC expression levels to control
expression level vs. CpG frequency. B) log2 of the ratio of CpG stimulated pDC expression levels to control expression level vs. ApT frequency.
doi:10.1371/journal.pone.0005969.g002
Table 1. The probability that the amount of 2-fold expressed genes in the lowest and highest 10% and 25% could have occurred
randomly given the whole genome distribution, calculated for both the frequency and g distributions of a dinucleotide
(probabilities less than 0.00001 are listed as 0).
Dinucleotide Frequency g
Low 25% High 25% Low 10% High 10% Low 25% High 25% Low 10% High 10%
CG 0.00014 - 0 - 0.00080 - 0 -
C T - ----0.00367 - -
GA - 0.00080 - - - 0.00585 - 0.00078
G C 0 . 0 0 3 6 7 ----- - -
G G 0 . 0 0 5 8 4 ----- - -
T C - ----0.00367 - -
doi:10.1371/journal.pone.0005969.t001
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clear: the most expressed set of genes has a much stronger pressure
to have a low CpG content than do mouse genes in general, and
this pressure cannot be explained by nucleotide frequency alone.
That is, these genes are not low in CpG simply because they are
located in a low GC-content region. This CpG pressure is clearly
the most significant dinucleotide characteristic of the expressed
genes.
This conclusion is further reinforced by the data in Table 3,
where we look at the tenths and quartiles for single nucleotide
content and AT and GC content at the 4-fold levels, as there is no
significance at the 2-fold level. This analysis also further clarifies
whether or not the dominant statistical pressure is GC bias or CpG
pressure, indicating experimental error that should be accounted
for in the original GCRMA normalization procedure. At the single
nucleotide level, shown in Tables 4 and 5, A content is persistently
abundant in the highest 10% level and G and C content are
persistently scarce at the quartile level. There is also a lower
amount of GC content and a higher amount of AT content,
though the p-values associated with these effects are lower than the
p-values of those for CpG dinucleotides, indicating that CpG is the
dominant pressure. Combining these facts with the highly
significant g values for low CpG implies that CpG pressure is
the driving force behind the relatively low GC content and high A
content in this location compared to the rest of the genome. In our
previous work we noticed that the lowering of CpG in the H1N1
genome over 90 years of infection in human hosts appeared to be
compensated for by an increase in TpA. In this case, there is a
relative abundance of GA. Both cases favor an increase in A
content, presumably from G to A mutations, as a byproduct of
CpG avoidance. This is also reinforced by the significant A
abundance without a compensating T abundance. Thus we
conclude that genes encoding functions of the innate immune
response avoid CpG in coding regions – as we hypothesized they
should – to avoid a positive feedback loop of innate immune
response.
We further use these data to classify important innate immune
genes by combining high expression with significant CpG
avoidance. In Table 6, we look at the median frequency of the
4-fold expressed genes in pDCs that are both exposed to influenza
and are in the lowest tenth of CpG frequency. Next, we compare
Table 2. Biases in expression data that persist at the 4-fold expression level.
Dinucleotide Frequency g
Low 25% High 25% Low 10% High 10% Low 25% High 25% Low 10% High 10%
AA - 0.00005 - 0.00033 - - - -
AT - 0.00693 - - - - - -
CC 0.00477 - - - - - - -
CG 0.00059 - 0 - 0.00477 - 0.00002 -
GA - 0.00693 - - - 0.00692 - 0.00338
GC 0.00001 - 0.00568 - - - - -
GG 0.00324 - - - - - - -
TC - - - - - 0.00014 - -
doi:10.1371/journal.pone.0005969.t002
Table 3. GC and AT content bias in 4-fold expressed genes,
which are generally weaker and can be accounted for by the
dinucleotide bias.
4-fold Low 25% High 25% Low 10 % High 10 %
AT% - 0.00023 - 0.00061
GC% 0.00023 - 0.00061 -
doi:10.1371/journal.pone.0005969.t003
Table 4. Nucleotide content bias in 2-fold expressed genes,
which are again weaker and can be accounted for by
dinucleotide bias.
2-fold Low 25% High 25% Low 10% Hi 10%
A% - - - -
C% - - - -
G% 0.00911 - - -
T% - - - -
doi:10.1371/journal.pone.0005969.t004
Table 6. Median values of the CpG frequency influenza
induced expressed mouse genes in the lowest 10% of overall
mouse genome CpG frequency, along with the median CpG
frequency in orthologous avian and human genes.
Mouse Avian Human
Flu 0.0112 0.0311 0.0083
doi:10.1371/journal.pone.0005969.t006
Table 5. Nucleotide content bias in 4-fold expressed genes.
4-fold Low 25% High 25% Low 10% High 10%
A% - 0.00059 - 0.00568
C% 0.00991 - - -
G% 0.00009 - - -
T % --- -
doi:10.1371/journal.pone.0005969.t005
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human and avian mRNA derived from the HGNC database. The
median CpG frequency of homologs of this gene group is even
lower in humans than in mice. However, in chickens, the CpG
frequency is much higher, suggesting that this CpG pressure is less
significant in an avian influenza host. The genes in this group are
listed in Table 7. The genes with the largest difference in CpG
content between human and chicken orthologs from within this
group are predominantly cytokines. The largest difference is found
in the cytokine IL6. Its fraction of CpG as a total percentage of
dinucleotides is 0.0094 in mouse and 0.016 in human, while it is
0.10 in chicken. In fact, while the g value for this gene is 0.22 in
mouse and 0.25 in human, in chicken it is a close to the expected
value of 1.03. Following closely behind IL6 are the Type I
interferon genes and IL1-type cytokines. Thus a comparison of
many innate immune genes expressed in mouse pDCs infected
with influenza shows that these genes have significantly low CpG
dinucleotide levels in mouse and human, but not in chickens. This
mirrors the CpG levels in human versus chicken influenza from
[4].
Now that a dinucleotide pattern has been established, we can
focus our attention on longer over- and under-represented motifs
in viral genomes and the CDS regions of innate immune expressed
genes. We focus on motifs of length four, rather than six or eight,
since shorter motifs afford a greater statistical accuracy and we
desire sequences greater than codon length. We cannot do this
with individual genes, due to the short length of several innate
immune genes, so we randomize within individual genes, but
count the occurrence of motifs across a whole class of highly
expressed genes. To qualify a motif as over- or under-represented,
we use the criteria given by Karlin in Ref. [28]. In that work, an
odds ratio of greater than 1.23 is deemed over-represented and less
than 0.78 is deemed under-represented. The justification given in
that work is that the distribution of the log-odds ratio approaches a
normal distribution. This threshold corresponds to a probability of
Table 7. List of the expressed mouse genes in the lowest
10% of mouse genome CpG frequency.
Serpinb2 0.0104
Rgs1 0.0119
Ptgs2 0.0143
Ifrg15 0.0051
Xcl1 0.0116
Fcgr4 0.0134
Mnda 0.0094
Ifi205 0.0074
Il1rn 0.0146
Prg3 0.009
Il1b 0.0136
Rnf24 0.0112
Tnfsf10 0.0149
Serpini1 0.0122
Fnbp1l 0.0135
Gbp2 0.0141
Ifi44 0.0103
Cpne3 0.0125
Mup2 0.0129
Mup1 0.0129
Ifna2 0.007
Ifna5 0.0035
Ifna4 0.0018
Ifna1 0.0035
Il6 0.0094
Tlr1 0.0113
Mpa2l 0.0136
Cd33 0.0139
Phca 0.0125
Gvin1 0.0059
Casp4 0.0107
Bcl2a1a 0.0116
2700019D07Rik 0.0106
Aftph 0.0118
Rel 0.0147
Tgtp 0.012
Fbxo39 0.0145
Gpr33 0.0108
Serpinb1b 0.007
D14Ertd668e 0.0094
Bex6 0.0058
EG240327 0.0148
Iigp1 0.0097
Ms4a4c 0.0088
Ms4a4b 0.0088
Ms4a6b 0.0082
Ms4a6d 0.004
Ifit2 0.012
Ifit1 0.0129
Cenpi 0.0138
Armcx6 0.0122
Cflar 0.0124
Pyhin1 0.0111
Ifi204 0.0075
Ifi203 0.0049
Ccl4 0.0108
1100001G20Rik 0.0052
Setdb2 0.014
Kpna3 0.0147
Apol7a 0.0103
Apol7c 0.0081
BC031441 0.0025
Il1rn 0.0131
Ifna6 0.0018
Zfp800 0.0146
Klrk1 0.0129
Klrk1 0.0106
AI451617 0.006
Il15 0.0082
BC050092 0.0146
doi:10.1371/journal.pone.0005969.t007
Table 7. Cont.
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occur randomly in a sequence greater than 5 kb.
In the innate genes, the approach of Ref. [28] yields many
significant CDS motifs at the 2-, 4-, and 8-fold mRNA expression
levels in the influenza stimulated genes, the CpG stimulated genes,
and the intersection of these groups. There is a strong overlap
between the under-represented motifs discovered. There are 64–
70 motifs in each group with the difference coming from marginal
cases close to the 0.78 cutoff value. Table 8 lists the ten most
under-represented motifs from the intersection of all pathogen-
stimulated groups. Next to them we list the ten most under-
represented motifs from the ssRNA viruses, for which we
performed the same search procedure. The most significant motifs
in the innate immune genes and the viruses that are the targets of
the innate immune response all contain CpG and have a strong
overlap: six of the ten most under-represented motifs are identical.
This clearly implies a specific sequence pressure common to both
groups. Table 9 shows the same results for over-represented
motifs. In Supplementary Tables S3, S4, S5, S6, S7, S8, we list all
of the motifs that qualify as over- or under-represented from each
group, as well as a table of the under- and over- represented motifs
from both of the viral and expressed gene groups. The genes, while
having many common motifs with the viruses, tend to have
stronger pressures and more significant motifs as a consequence.
They also have some non-CpG related motifs, unlike the viruses.
Finally, we examine the 90 year evolution of H1N1 influenza in
humans by looking at the context in which CpG dinucleotides
occur. The virus disappeared from the population in 1957 and
reemerged in 1977. The 1977 virus was anitgenically similar to
many 1950s H1N1 strains and, as a result, is thought to be the
result of a frozen sample that may have escaped from a lab [29]. It
is clear from Table 8 that the most under-represented motifs have
CpG in a context of As and Ts. Figure 3 of Ref. [4] shows a clear
decline in the CpG content of human influenza genomes. We now
separate the CpGs in the time series of H1N1 genomes into four
groups. The first is 4-mers of the form (C/G)CG(C/G), that is, a
CpG with either a C or a G on the left and a C or a G on the right.
The second is the group (A/U)CG(A/U), the third is (A/U)CG(C/
G), and the fourth is (C/G)CG(A/U). Figure 3 shows clearly that,
as the CpG frequency changes over time, the majority of the
change comes from eliminating the CpGs surrounded by A and U
nucleotides. In fact, the CpG dinucleotides surrounded by C and
G nucleotides are unselected; there is no discernable change in their
content. On the other hand, CpGs with a C or a G on one side
and an A or a U on the other, show a decline, but at
approximately half the rate as if there were an A or a U flanking
both sides of the CpG. Hence, it is not just CpGs that are being
targeted, but CpGs in a specific context. For contrast, it is also
shown that (A/U)GC(A/U) does not show a similar decline as (A/
U)CG(A/U), further establishing that GC content is not
responsible for this effect.
The fraction of CpGs flanked by As and Us starts at 0.0071 in
the 1918 H1N1 and ends with a median value of 0.0048 in the
2007 H1N1 samples. This initial value is higher than the median
value of 0.0064 from the avain viruses in the database and is
slightly higher than the median value of 0.0069 found in the lethal
H5N1 virus, though some of those samples were slightly higher
than in the 1918 flu. Comparatively, Influenza B has a value of
0.0042 and does not decline, suggesting that the recent H1N1 is
now closer to equilibrium, like Influenza B, than to the more lethal
variants. The expected pattern exists for the other groups, with the
(C/G)CG(C/G) bin having similar values amongst all samples and
the mixed motifs behaving like the (A/U)CG(A/U) bin, but more
weakly. The (A/U)CG(A/U) group, however, seems to be the
clearest target of possible selective pressure, as one would predict
from the most under-represented motifs in Table 8.
Discussion
From the above analysis, it is clear that there are shared di-,
tetra-, and hexanucleotide sequence biases between ssRNA viruses
and the mRNAs of host innate immune genes. These common
evolutionary pressures could be due to common mutational
processes or common selection forces. Hosts and ssRNA viruses do
not share common polymerases or replication machinery suggest-
ing that the most likely explanation is that common factors act in a
parallel way in host and pathogen. Hence we conclude that the
genomes of both influenza viruses and their hosts share a common
evolutionary selection pressure at the nucleotide sequence level to
eliminate CpGs in an AU context. By contrast, some hosts, like
avian species, have a less robust innate immune response to these
pressures and, therefore, tolerate influenza viruses with a greater
diversity of CpG frequencies. When a virus with a very high CpG
frequency jumps into the human population from the avian
reservoir, the human hosts may suffer from an acute innate
immune response. If this virus can still replicate under these
Table 8. The 10 most under-represented quadrameric motifs
in stimulated pDCs and ssRNA viruses, listed in order of
ascending r values.
Stimulated Genes ssRNA Viruses
CGAA 0.431 CGAT 0.540
TCGA 0.450 CGAA 0.542
CGAT 0.467 TTCG 0.548
GTCG 0.470 ACGA 0.548
CGTA 0.470 TCGA 0.549
GCGA 0.481 GACG 0.564
TACG 0.511 TACG 0.583
CGAC 0.515 TCGT 0.596
ACGA 0.524 GTCG 0.600
CCGA 0.544 ATCG 0.607
doi:10.1371/journal.pone.0005969.t008
Table 9. The 10 most over-represented quadrameric motifs
in stimulated pDCs and ssRNA viruses, listed in order of
descending r values.
Stimulated Genes ssRNA Viruses
TTTG 1.35 ACCA 1.29
ATGA 1.35 CCAC 1.27
TGTG 1.34 ACAC 1.26
GATG 1.32 CACA 1.25
CCAT 1.31 TGTG 1.24
GTGG 1.29 CACC 1.24
ACCA 1.27
CTGG 1.27
CATC 1.27
GCTG 1.26
doi:10.1371/journal.pone.0005969.t009
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In parallel, innate immune genes experience the same pressures to
avoid confounding autoimmune signals that could trigger harmful
positive feedback loops of cytokine expression. If host mRNA has
evolved to avoid a set of immunostimulatory receptors, then this
RNA must have a heightened level of exposure to PRRs at some
points during the innate response that would trigger receptors
were there PAMPs present. Hence, if an individual developed an
abnormal sensitivity via an allele to stimulating motifs, this could
clearly trigger a detrimental feedback loop and an associated
autoimmune disease. This logic, therefore, predicts which genes to
examine in some autoimmune diseases.
The evidence for the above comes from comparing the low
CpG selection pressure in the innate immune genes observed here
to the viral CpG selection pressure observed here and in Ref. [4].
In both cases, avoidance of CpG is the strongest signal present.
While that is suggestive, most convincing is the striking similarity
of underrepresented motifs of longer oligonucleotides. The nature
of the common pattern is clearly CpG in an AU context. It is clear
from Figure 3 that this is the CpG motif that the H1N1 virus has
been most strongly selecting against. Moreover, of the shared
motifs between the viruses and host genes, the 12 with lowest r
values all involve CpG surrounded by As and Us, and with similar
ranking. Certainly, if a known TLR that recognized CpG in RNA
existed, one would conclude that it is the cause of the observed
pattern. However, here we use the commonality of host and
pathogen motifs to predict the existence of a PRR for CpG in
RNA. The existence of such a receptor has some support, as CpG
rich ssRNA has been observed to stimulate an immune response
[9]. Moreover, these motifs are very similar to those for CpG DNA
that stimulates TLR9, as TLR9 binds to CpG in an AT rich DNA
context preferentially [30]. Thus, the notion of using overlapping
host and pathogen signals for PRR prediction seems plausible as
this work clearly predicts a (U/A)CG(U/A) RNA receptor or, at
the very least, some other equivalent mechanism driven by a
nucleic acid signal.
Viral databases of nucleotide sequences offer an additional
opportunity because RNA viruses evolve rapidly on short time
scales. H1N1 influenza, which is known from our previous work to
have been lowering its CpG content over the past 90 years in
human hosts, clearly has been doing so in a heavily biased fashion.
The 1918 virus began its life at a level of CpG in an AU context
most associated with avian viruses and only seen comparably in
human strains in the highly pathogenic H5N1 virus. It has been
evolving to lower this signal ever since, and is currently at a level
closer to Influenza B, a virus in equilibrium with the human
population over a comparatively long time frame. Likewise, when
looking across species, the innate immune genes that most avoid
theses motifs do so in human and mouse, but not in chicken. This
empirically supports the speculation of the previous work that the
virulence of the 1918 strain, and the cytokine storm implicated as a
mechanism of high pathogenesis in this strain [31], may have been
due in part to an abundance of non-self avian CpG signal that
overstimulated the human innate immune system. Moreover,
Figure 3. Evolution of the CpG frequency of H1N1 influenza A virus in time, binned by CpG context for the following four sets of bins:
A) CpGs ‘‘protected’’ by Cs and Gs. B) CpGs surrounded by As and Us. C) CpGs with a C or G on the right and an A or U on the left. D) CpGs with a C
or G on the left and an A or U on the right. E) In contrast, this figure shows GpCs surrounded by As and Us. There is no decline as observed in (B).
doi:10.1371/journal.pone.0005969.g003
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efficient polymerase than current circulating H1N1 strains [32]
would further support the results here, since this would have
caused the 1918 virus to present even more immunostimulating
motifs to PRRs.
The degree to which the biases in genes identified by this study
are representative of trends in the innate immune response as a
whole is not clear. The public mouse expression data used in this
study uncovered a set of highly expressed pDC genes for CpG in
DNA and a different, but strongly overlapping, set from influenza.
This raises a general question of what genes are broadly expressed
when a pathogen stimulates a cell and what genes are only
expressed for a specific set of pathogens and cell types. In humans,
myeloid dendritic cells express TLRs 7 and 8, whereas the pDCs
studied here express TLR 7 and TLR 9 [13]. Certainly, a one
would like to repeat the experiments of Ref. [19] in human pDCs,
as well as in other relevant human and non-human cell types.
Studies of the innate immune response between cell types can
differentiate the specificity of these receptors and further
characterize the important non-self RNA signals. Our approach
could be generalized beyond RNA to other non-self patterns in
proteins or other materials.
Since different pathogens cause different gene expression
patterns of innate immunity, it would be naı ¨ve to assume that
we have fully probed the extent to which gene expression is pattern
specific. While it is clear from this study that expressed innate
genes are often drastically low in CpG, it is not clear to what
extent this drives overall CDS CpG pressure. CpG is certainly low
for many reasons, and in DNA, methylation and deamination are
considered the primary causes [33–35]. However, we would
hypothesize that this or some other process led to CpG in RNA, as
well as the CpG in DNA detected by TLR 9, becoming a non-self
signal in certain mammals. This further drove a subset of genes in
these species to have an extremely low CpG content, even compared
to the genome as a whole. The group of genes with a CpG
frequency amongst the lowest 10% of CDS regions contains many
other genes that were not expressed by either of the two stimulants
here. A complete list of these genes is provided in Supplementary
Tables S9 and S10. It will be interesting to learn what fraction of
these genes have a role in innate immunity, and to what extent
extremely low CpG content is driven by innate immune pressure.
There are many suggestive genes with low CpG frequency, such as
C-type lectin doman family and zinc finger genes, along with other
cytokines, that likely have innate immune functions. However,
genes such as olfactory receptors and keratin-associated proteins
also have low CpG frequency and their connection to innate
immunity is not clear. This paper points out a new set of criteria to
classify the innate immune response. As such, new genes are
identified that we have presently no reason to classify as part of the
innate immune response, but nevertheless may be. Only by
continuing to probe a diversity of host cell types with a diversity of
pathogens, and by quantifying the unusual patterns common to
both, will we discover the extent to which the self/non-self
distinction has simultaneously driven both host and pathogen
evolution.
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